ImpediMed Limited (ASX:IPD) Announces Q3 Revenue and ARR Growth
ImpediMed Limited (ASX:IPD) reports record Q3 revenue and ARR growth, along with key operational and management developments.
Category: ASX-IPD
ImpediMed Limited
Latest News
KALiNA Power Limited (ASX:KPO) Advances AI Data Centre Projects and Secures Funding
Dimerix Limited (ASX:DXB) Secures Major Licensing Deal in Japan and FDA Endorsement for DMX-200
Australian Gold and Copper Ltd (ASX:AGC) Accelerates Achilles Exploration Program in 2025
Cobre Limited (ASX:CBE) Secures BHP Agreement and Reports Strong Exploration Results
BPH Global Limited (ASX:BP8) Releases Quarterly Activities Report and Secures Funding
ImpediMed Limited (ASX:IPD) Announces Q3 Revenue and ARR Growth
Wisr (ASX:WZR) Upgrades FY25 Guidance with Strong Q3 Results
Origin Energy Limited (ASX:ORG) Releases March 2025 Quarterly Report
Coles Group Limited (ASX:COL) Announces Third Quarter Sales Results
Appen Limited (ASX:APX) Releases Q1 FY25 Performance Report
The Hub of Australian Finance News